The subject device has not been returned to olympus medical systems corp.But was returned to olympus (b)(4).Following additional high level disinfection at (b)(4), the subject device was send to a third party laboratory for additional microbiological testing.In the additional test, the testing indicated no microbial growth for the channels of the subject device.Omsc reviewed the manufacture history of the subject device and confirmed no irregularity.The exact cause could not be determined at present.
|
Olympus medical systems corp.(omsc) was informed that during routine surveillance culturing test by the facility, the subject device continuously tested positive for several microorganism three times.On (b)(6) 2017, the biopsy channel tested positive for klebsiella variicola and escherichia coli.The air/water channel tested positive for klebsiella oxytoca and enterobacter cloacae (>100cfu/100ml: total cfu from the channels).On (b)(6) 2017, the biopsy channel tested positive for achromobacter sp., escherichia coli and klebsiella variicola (>100cfu/100ml in total).The test indicated no microbial growth for the air/water channel.On (b)(6) 2017, the biopsy channel tested positive for coagulase negative staphylococcus.The air/water channel tested positive for coagulase negative staphylococcus and pseudomonas aeruginosa (7cfu/100ml: total cfu from the channels).The facility had reprocessed the subject device using non-olympus automated endoscope reprocessor (soluscope) with peracetic acid.There was no report of infection associated with this report.
|